Publications by Career Development Program Trainees

Grant Cycle Two (2007 - 2012)

Publications

1. Morrissey C, Vessella RL. The role of tumor microenvironment in prostate cancer bone metastasis.
   J Cell Biochem. 2007 Jul 1;101(4):873-86. Review.
   PMID: 17387734
   
2. Morrissey C, Kostenuik PL, Brown LG, Vessella RL, Corey E. Host-derived RANKL is responsible for osteolysis in a C4-2 human prostate cancer xenograft model of experimental bone metastases.
   BMC Cancer. 2007 Aug 3;7:148.
   PMID: 17683568
   
3. Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, Nelson C, Gleave M. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Cancer Research 2007. Nov 1;67(21):10455-65.
   PMID: 17974989
   
4. Sowery RD, Hadaschik BA, So A, Zoubeidi A, Fazli L, Hurtado-Coll A, Gleave ME. Clusterin knockdown using the antisense oligonucleotide OGX-011 re-sensitizes docetaxel-refractory prostate cancer PC-3 cells to chemotherapy. BJU 2008 Aug;102(3):389-97
   PMID: 18336596
   
5. Hadaschik BA, Ettinger S, Sowery RD, Zoubeidi A, Andersen RJ, Roberge M, Gleave ME, Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. Int J Cancer. 2008 May 15;122(10):2368-76.
   PMID: 18240145
   
6. Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of megalin genetic polymorphisms with prostate cancer risk and prognosis. Clinical Cancer Research, 2008 Jun 15;14(12):3823-31.
   PMID: 18559602
   
7. Holt S.K., Salinas C.A., Stanford J.L. Vasectomy and risk of prostate cancer. Journal of Urology, 2008 Dec;180(6):2565-7; discussion 2567-8
   PMID: 18930503
   
8. Morrissey C, True LD, Roudier MP, Coleman IM, Hawley S, Wang Y, Corey E, Lange PH, Higano CS, Nelson PS, Vessella RL. Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases. Clin Exp Metastasis. 2008;25(4):377-88
   PMID: 17972146
   
9. Lucas JM, True L, Hawley S, Matsumura M, Morrissey C, Vessella RL, Nelson PS. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. J Pathol. 2008 Jun;215(2):118-25.
   PMID: 18338334
   
10. Roudier MP, Morrissey C, True LD, Higano CS, Vessella RL, Ott SM. Histopathological assessment of prostate cancer bone osteoblastic metastases. J. Urol. 2008 Sep;180(3):1154-60
    PMID: 18639279
    
11. Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, Sadar MD, English J, Fazli L, So, A, Gout PW,  Gleave ME, Squire JA, Wang YZ. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Research. 2008 Jun 1;68(11):4352-9.
    PMID: 18519696
    
12. Narita S, So A, Ettinger S, Hayashi N,  Muramaki M, Fazli L, Kim Y, Gleave M.  GLI2 knockdown using an antisense oligonucleotide induces apoptosis and chemosensitizes cells to paclitaxel in androgen independent prostate cancer. Clinical Cancer Research 2008 Sep 15;14(18):5769-77
    PMID: 18794086
    
13. Wu, J.D., C.L. Atteridge, X. Wang, T. Seya, S. R. Plymate. Obstructing shedding of the immunostimulatory MHC class I chain-related gene B prevents tumor formation. Clin Cancer Res 2009 Jan 15;15(2):632-40.
    PMID: 19147769

Book Chapters

1. Tanya Day, PhD
   Invited book chapter for a book entitled "Androgen Action in Prostate Cancer" (Chapter ref: Day, T.K., Nelson, C.C. & Gleave, M.E., Differential regulation of clusterin isoforms by the androgen receptor)

Meetings

1. Telesca D, Higano CS, Yu EY, Montgomery RB, Tam S, Russell KJ, Nelson PS, Etzioni RB.  Duration of the first off treatment period is associated with time to androgen independence (AI) and survival in men with localized or biochemical relapse of prostate cancer treated on prospective trial of intermittent androgen deprivation (IAD).  2007 ASCO Annual Meeting, Chicago, IL. J Clin Oncol  2007 ASCO Annual Meeting Proceedings Part I. 25(18S):5146.
   
2. Gulati R, Yu EY, Telesca D, Jiang P, Montgomery RB, Tam S, Russell KJ, Nelson PS, Etzioni RB, Higano CS.  Testosterone kinetics in the first cycle of intermittent androgen deprivation for men with localized or biochemical relapse of prostate cancer.  2008 ASCO Annual Meeting, Chicago, IL.